Home
Scholarly Works
USE OF DUAL PATHWAY INHIBITION FOR SECONDARY...
Journal article

USE OF DUAL PATHWAY INHIBITION FOR SECONDARY PREVENTION IN PATIENTS WITH ATHEROTHROMBOTIC DISEASE: THE PROSPECTIVE REAL-WORLD XATOA STUDY

Authors

Zeymer U; Aboyans V; Cowie MR; Debus ES; Gay A; Vogtländer K; Anand S; Fox KAA

Journal

Journal of the American College of Cardiology, Vol. 79, No. 9,

Publisher

Elsevier

Publication Date

March 8, 2022

DOI

10.1016/s0735-1097(22)02737-1

ISSN

0735-1097

Contact the Experts team